anonymous
Guest
anonymous
Guest
There was a clear overreaction in the marketplace based upon the Merck data. Granted, that data looks pretty good, but let’s keep in mind, A bird in the hand is worth two in the bush. We got a great asset today and some really solid data now going forward. I look for some significant upside from here, we do better and we go higher.